weve intrigu wide-rang strateg oper updat
support
 fundament share price
perform proactiv chang portfolio price/mix approach bottl
system oper model cultur yield seri win across busi
culmin yoy organ sale growth ytd importantli
sinc better growth root fundament chang even see earli evid
compani long-term goal yoy revenu growth achiev
time elev growth profil improv profit increasingli
make ko deserv greater valuat premium rel stapl peer view
back-half outlook feel secur think share ralli
see rotat back stapl would expect investor
favor stock solid long-term prospect high degre near-term ep
visibl think ko clearli check box regard ep visibl
specif note ko abl maintain full-year rang even
fx headwind oper incom that becom oner sinc
start year ep deliveri support solid top-lin momentum
product flow think commit meet dollar ep target
noteworthi chang ko messag ceo jame quincey previou call
abil execut comprehens portfolio transform micro level
differenti factor sure current degre portfolio activ ko
inclus core innov new product packag price sku trim feel
almost unparallel histori cover stapl importantli attribut
success to-dat due larg local oper model allow in-market
tweak feedback global bottl system support execut store-
by-stor basi thu enabl strategi implement micro level oper
model bottl system increasingli emerg key asset given fragment
local tast help ko continu gain share pt
ko quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
link barclay live interact chart
transform re-acceler top bottom
line compani demonstr abil
sustain deliv algorithm expect
valuat credit given
upsid case assum ko trade
price-to-earnings upsid ep
downsid case assum ko trade
price-to-earnings downsid ep
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
yesterday coca-cola compani report compar ep
compar consensu barclay research rel model
oper perform roughli penni better support organ sale beat
yoy vs yoy off-set lighter profit margin expans
bp vs bp line item penni oner
stock remark strong top-lin result organ sale
signal us transform deliv result expect
compani better top-lin growth profil model yoy year next
reflect increas valuat premium large-cap stapl versu histor norm
top-lin momentum product help give us confid ko deliv
full-year ep target bullish ko would recommend strong
perform next sever year price target base price-to-earnings
ep estim repres premium large-cap stapl prior
price target base price-to-earnings ep estim also
repres premium large-cap stapl increas price target given
multipl expans large-cap stapl group sinc last publish ko
weve intrigu wide-rang strateg oper updat
support inflect fundament share price perform
weve focus stapl compani cope signific
industri chang weve come see ko leader regard specif note
ko evolv aspect busi rang portfolio strategi price/mix
realiz re-shap global bottler footprint implement new oper
model greater region respons underpin updat focu cultur
chang ko look becom agil will take risk fast-mov
dynam competit environ chang may seem softer
natur believ directli respons seri key win zero
sugar diet flavor global lift shift key brand fuze
smartwat honest etc enabl ko re-acceler top-lin
rang complet thought strateg transform see
compani upgrad ow sparkl transform
back-half outlook feel secur think share ralli
investor seem rotat back stapl name given geopolit
uncertainti expect favor name best posit manag
 even thrive despit structur long-term pressur space
rel high degre near-term ep visibl first point weve outlin
prior work think ko succeed long-term second point
note given high degre intern exposur profit outsid
 compani typic seen larg swing ep amidst macro currenc
volatil structur exposur intern market increas post-
refranchis sure remain risk think ko better posit manag
fx volatil given top-lin momentum ampl product weve
seen evid far fx drag oper profit worsen
bp sinc begin year ko still maintain dollar
ep guidanc rang growth part thank better organ sale growth
see noteworthi chang ko first signal greater commit
deliv dollar ep prior cagni
abil execut comprehens portfolio transform micro level
differenti factor earli work ko highlight differ
aspir execut challeng compani well broader stapl
space see compani oper model chang enabl
sure aspir high current degre portfolio activ inclus core
innov new product packag price sku trim stand
among ambiti weve seen time cover stapl think one
critic perhap underappreci driver success abil implement
strateg initi micro level execut exampl would point
local oper model allow uniqu in-market tweak insight attent
exemplifi adjust fuze tea adez launch europ
year coffe product vietnam highlight yesterday call
similarli global bottl system allow tailor store-by-stor execut
global basi capabl would argu almost stapl peer fulli
match view oper model bottl system key factor
abil execut global portfolio transform expect becom
valuabl fragment local tast competit acceler
updat model weve tweak organ sale estim
reflect stronger result vs slightli greater back-
half momentum segment basi weve tweak north america price/mix
full-year flat reflect weaker expect result driven
factor includ freight cost time deduct mix result pricing-driven
juic volum declin look ahead ko increas price csd back half
expect price increas stick consum level note flow-through
 may slightli less bottler ls price increas seem aim
part help bottler off-set inflat think flat north america price/mix
full-year impli realist expect hand weve
increas latin america price/mix full-year vs previous includ
price/mix versu previous greater inflat price initi
benefit emea note expect concentr sale run ahead
case sale full-year fuze tea launch replac nestea partnership
partial contributor gap ytd would expect persist full-
year basi turn profit full-year oper margin estim lower
bp given lighter result pressur fx though stronger top-lin
slightli greater below-the-lin favor allow us maintain ep estim
weve lower ep penni reflect oner fx impact
oper incom level versu prior expect expect organ
sale growth report oper incom growth includ fx
lauren lieberman herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
